Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate : a Janus-faced substance?
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Sphingolipids: important players in multiple sclerosis.
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
Fast facts: multiple sclerosis.
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
Acute paraplegia caused by Schistosoma mansoni.
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
Fingolimod and multiple sclerosis: Four cautionary tales.
Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
The story of neuromyelitis optica continues to be written.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
Pages
« first
‹ previous
…
353
354
355
356
357
358
359
360
361
…
next ›
last »